Find clinical trials for Acute Myeloid Leukemia (AML) in Kansas City, KS
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Acute Myeloid Leukemia (AML) trials near Kansas City, KS, USA:
allogeneic hematopoietic stem cell transplant (HCT), versus Conventional Care in patients with Active, Relapsed or Refractory Acute Myeloid...
Phase 3
Westwood, Kansas, United States and 23 other locations
study of five dose levels of APVO436 in combination with venetoclax and azacitidine (ven/aza) in adult patients with newly diagnosed, CD123+ AML...
Phase 1
Fairway, Kansas, United States and 6 other locations
AML that cannot or elect not to be treated with more intensive chemotherapy; (2) whether BP1001-based treatment provides greater efficacy (....
Phase 2
Fairway, Kansas, United States and 8 other locations
\[GO\]) improves survival of children/adolescents/young adults with acute myeloid leukemia (AML) in 1st relapse w...
Phase 3
Kansas City, Missouri, United States and 87 other locations
Ziftomenib is an investigational drug in development for the treatment of patients with acute myeloid leukemia (AML...
Phase 1
Fairway, Kansas, United States and 43 other locations
pharmacokinetics, pharmacodynamics and preliminary efficacy of ZE46-0134 in patients with FLT3 and spliceosome mutated Relapsed or Refractory Acute...
Phase 1
Lawrence, Kansas, United States and 22 other locations
in combination with venetoclax for the treatment of newly diagnosed acute myeloid leukemia (AML) in adults who ar...
Phase 1, Phase 2
Kansas City, Missouri, United States and 33 other locations
This is a multi-center, randomized, double-blinded, placebo controlled trial.
Phase 3
Westwood, Kansas, United States and 105 other locations
An open-label, phase I, multi-center study to determine in relapsed/refractory (r/r) acute myeloid leukemia (AML)...
Phase 1
Fairway, Kansas, United States and 4 other locations
safe and if they have beneficial effects in treating patients with acute myeloid leukemia (AML) or acute ...
Phase 1
Kansas City, Missouri, United States and 7 other locations
Clinical trials
Research sites
Resources
Legal